MétaCan
Menu
← Back to cohort
Record W2791044247 · doi:10.1093/jcag/gwy008.093

A92 ANTIBIOTICS FOR INDUCTION AND MAINTENANCE OF REMISSION IN CROHN’S DISEASE

2018· article· en· W2791044247 on OpenAlexaff
Cassandra Townsend, Claire E. Parker, J MacDonald, Brian G. Feagan, Vipul Jairath, Reena Khanna

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2018
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsCochraneRobarts Clinical TrialsWestern University
Fundersnot available
KeywordsMedicinePlaceboInternal medicineRelative riskClarithromycinCochrane LibraryRifaximinRandomized controlled trialNumber needed to treatConfidence intervalMeta-analysisMetronidazoleRandomizationAntibioticsBlindingPathology

Abstract

fetched live from OpenAlex

Trials of antibiotic therapy for Crohn’s disease (CD) have produced conflicting results. We performed a systematic review and meta-analysis to determine the efficacy and safety of antibiotics for induction and maintenance of remission in CD. EMBASE, MEDLINE, the Cochrane Library and the Cochrane IBD Group Specialized Register were searched from inception to September 2016. Randomized controlled trials (RCTs) comparing antibiotics to placebo or an active comparator in CD patients were considered for inclusion. Data were analyzed based on intention-to-treat. Risk ratios (RR) and corresponding 95% confidence interval (95% CI) were calculated for dichotomous outcomes. The primary outcome was the number of patients who failed to achieve clinical remission. Methodological quality was assessed using the Cochrane risk of bias tool. GRADE was used to assess the overall quality of the evidence for the primary outcome. Fourteen RCTs (n = 1469 patients) were eligible. Two trials were rated as high risk of bias (no blinding). Eight trials were rated as unclear risk of bias and 4 trials were rated as low risk of bias. Ciprofloxacin, metronidazole, clarithromycin, rifaximin and cotrimoxazole were evaluated at therapeutic doses. Comparisons included antibiotic vs. placebo, antibiotic vs. steroid, antibiotic vs. placebo in addition to usual therapy and antibiotic vs. placebo in addition to biologic therapy. A pooled analysis of 8 placebo-controlled RCTs (801 patients) showed no significant difference in clinical remission at 6 to 10 weeks. Fifty per cent (267/535) of antibiotic treated patients failed to enter remission compared to 59% (158/266) of placebo patients (RR 0.87, 95% CI 0.75–1.01; moderate quality evidence). A pooled analysis of two placebo-controlled studies (155 patients) showed no statistically significant difference in relapse rates at 52 weeks. Forty-five per cent (37/83) of antibiotic treated patients relapsed compared to 57% (41/72) of those assigned to placebo (RR 0.87, 95% CI 0.52–1.47; low quality evidence). There were no statistically significant differences between antibiotics and placebo in the proportion of patients with adverse events (RR 0.87, 95% CI 0.75–1.02; 9 studies; 852 patients), serious adverse events (RR 1.12, 95% CI 0.26–4.76; 4 studies; 555 patients), or withdrawal due to adverse events (RR 0.86, 95% CI 0.57–1.29; 9 studies; 858 patients). Antibiotics are ineffective for induction or maintenance of remission in Crohn’s disease. None

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.024
metaresearch head score (Gemma)0.059
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.024
Threshold uncertainty score0.130

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0240.059
Meta-epidemiology (narrow)0.0030.002
Meta-epidemiology (broad)0.0140.021
Bibliometrics0.0120.009
Science and technology studies0.0010.002
Scholarly communication0.0050.003
Open science0.0020.002
Research integrity0.0050.002
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.221
Teacher spread0.216 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of Gastroenterology→Same topicInflammatory Bowel Disease→French-language works237,207→